Media

Feature Coverage


Biotechnology requires massive investment: CEO John Crowley

John Crowley, CEO of Amicus Therapeutics, discusses his biotechnology business model, as well as drugs pricing.

John Crowley on CNBC Squawk Box

Amicus Therapeutics (FOLD) CEO John Crowley 'Squawk Box' on CNBC

John Crowley on CNBC Squawk Box

Amicus Therapeutics CEO: Driving science to a cure

John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC's Jim Cramer.

John Crowley

Click Here to Read the Article


One Dad’s 14-Year Quest for Cure

By GEETA ANAND

Seven months ago, Megan Crowley made a gutsy decision: to undergo a radical surgery to straighten out her spine, which has been crippled by Pompe disease. Photo: Lexey Swall

Megan Crowley

Click Here to Read the Article

Click Here to View the Video